Baillie Gifford & CO Fibrogen Inc Transaction History

Baillie Gifford & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$15.95 - $25.18 $1,148 - $1,812	72 Added 15.42%	539 $10,000
Q2 2021 Aug 02, 2021	BUY	$18.57 - $35.68 $1,671 - $3,211	90 Added 23.87%	467 $12,000
Q1 2021 May 06, 2021	BUY	$31.0 - $55.72 $930 - $1,671	30 Added 8.65%	377 $13,000
Q4 2020 Feb 10, 2021	BUY	$37.09 - $48.97 $12,870 - $16,992	347 New	347 $13,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

Stay updated on Baillie Gifford & CO with notifications on news.